Literature DB >> 20863528

Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.

Rupak Mukherjee1, Jonathan M Snipes, Stuart M Saunders, Juozas A Zavadzkas, Francis G Spinale.   

Abstract

BACKGROUND: Left ventricular (LV) remodeling following myocardial infarction (MI) is associated with increased levels of specific matrix metalloproteinases (MMPs) and relative reduction of endogenous tissue inhibitors of the MMPs (TIMPs). However, transcriptional mechanisms for the disparate post-MI MMP/TIMP expression remain unknown. Using murine constructs designed to report gene promoter activation, this study tested the hypothesis that distinctly different temporal profiles of MMP-2, MMP-9, and TIMP-1 transcription occurs post-MI. METHODS/
RESULTS: Transcriptional activity (β-galactosidase (β-gal) reporter constructs) of MMP-2 (n = 49), MMP-9 (n = 62), or TIMP-1 (n = 40) was assayed at 1 h (acute), and 1-28 d after MI (coronary ligation) in transgenic reporter mice. At 7 d post-MI, the area of promoter activation normalized to LV area was increased from acute values for MMP-2 (63.4 ± 5.8 versus 1.1% ± 1.0%, P < 0.05) and MMP-9 (53.1 ± 6.1 versus 1.3% ± 0.9%, P < 0.05). While TIMP-1 promoter activation at 7 d post-MI increased from acute values (3.6 ± 1.3 versus 0.3% ± 0.5%, P < 0.05), this increase was smaller than that for MMP-2 or MMP-9 (both P < 0.05). MMP-2 promoter activation peaked in the MI region at 7 d post-MI and MMP-9 promoter activation was highest in the border region at 7 and 14 d post-MI. TIMP-1 promoter activation peaked within the MI region at 7 d post-MI and within the remote region at 14 d post-MI.
CONCLUSIONS: These findings provided direct in vivo evidence that discordant changes in temporal and spatial patterns of MMP/TIMP transcription occurs with MI. Restoration of TIMP-1 promoter activation may represent a molecular therapeutic target to attenuate/prevent adverse post-MI LV remodeling.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863528      PMCID: PMC3010347          DOI: 10.1016/j.jss.2010.06.015

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  36 in total

1.  Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.

Authors:  Jack P M Cleutjens; Esther E J M Creemers
Journal:  J Card Fail       Date:  2002-12       Impact factor: 5.712

2.  Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.

Authors:  J T Peterson; H Li; L Dillon; J W Bryant
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

3.  Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit.

Authors:  A M Romanic; C L Burns-Kurtis; B Gout; I Berrebi-Bertrand; E H Ohlstein
Journal:  Life Sci       Date:  2001-01-05       Impact factor: 5.037

Review 4.  Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction.

Authors:  Jeanine D'Armiento
Journal:  Trends Cardiovasc Med       Date:  2002-04       Impact factor: 6.677

5.  Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models.

Authors:  B I Jugdutt; M J Joljart; M I Khan
Journal:  Circulation       Date:  1996-07-01       Impact factor: 29.690

6.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.

Authors:  L E Rohde; A Ducharme; L H Arroyo; M Aikawa; G H Sukhova; A Lopez-Anaya; K F McClure; P G Mitchell; P Libby; R T Lee
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

7.  Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice.

Authors:  Esther E J M Creemers; Jeniffer N Davis; Andrea M Parkhurst; Peter Leenders; Kathryn B Dowdy; Elizabeth Hapke; Anne M Hauet; Patricia G Escobar; Jack P M Cleutjens; Jos F M Smits; Mat J A P Daemen; Michael R Zile; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-26       Impact factor: 4.733

8.  Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice.

Authors:  A M Flenniken; B R Williams
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

Review 9.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

10.  Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling.

Authors:  R Mohan; W B Rinehart; P Bargagna-Mohan; M E Fini
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

View more
  1 in total

1.  Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis.

Authors:  Cerrone R Foster; Laura L Daniel; Christopher R Daniels; Suman Dalal; Mahipal Singh; Krishna Singh
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.